Vitamin A

Vitamin A operates through three distinct mechanistic layers: the visual cycle in photoreceptors, nuclear receptor (RAR/RXR) transcriptional regulation in every nucleated cell, and non-genomic effects on membrane signaling and cellular differentiation. Understanding each requires tracking the molecular species — retinol, retinal, retinoic acid, and the retinyl esters — through absorption, storage, release, and target-tissue activation.

Dietary absorption. Preformed vitamin A in animal foods exists predominantly as retinyl palmitate (and other long-chain retinyl esters). Gastric and pancreatic lipases hydrolyze retinyl esters to free retinol in the small intestinal lumen, which partitions into mixed micelles for uptake into enterocytes via the intestinal brush-border transporter STRA6 and passive diffusion. Inside enterocytes, retinol is re-esterified by LRAT (lecithin:retinol acyltransferase) and incorporated into chylomicrons along with dietary triglycerides and other fat-soluble vitamins. Chylomicrons enter lymphatics and reach systemic circulation via the thoracic duct, then deliver retinyl esters primarily to the liver, with some uptake by peripheral tissues.

Provitamin A carotenoids (β-carotene, α-carotene, β-cryptoxanthin) enter enterocytes through SR-B1 and other scavenger receptors, then are cleaved centrally by β-carotene 15,15'-dioxygenase (BCO1) to yield two retinal molecules per β-carotene (theoretically) or eccentrically by BCO2 to yield apocarotenoids. The retinal products are reduced to retinol by enterocyte retinol dehydrogenases (RDH), esterified by LRAT, and packaged into chylomicrons alongside preformed vitamin A. Common BCO1 polymorphisms (T170M rs7501331, A379V rs12934922) reduce conversion efficiency by 30-70% in carriers (Leung 2009), explaining inter-individual variability in β-carotene responsiveness.

Hepatic storage. Chylomicron remnants are taken up by hepatocytes, where retinyl esters are either maintained within hepatocytes or transferred to hepatic stellate cells (perisinusoidal Ito cells), the body's primary vitamin A reservoir. A well-nourished adult stores 50-500 mg of retinol equivalents in hepatic stellate cell lipid droplets. Stellate cells activate and lose their vitamin A stores during liver fibrosis — a contributing mechanism to retinol deficiency in advanced liver disease.

Release and transport. When hepatic retinol release is signaled (low serum retinol, target-tissue demand), stellate cells transfer retinol back to hepatocytes, where retinyl esters are hydrolyzed by REH (retinyl ester hydrolase) to free retinol. Retinol is bound by retinol binding protein 4 (RBP4) secreted by hepatocytes, which complexes 1:1 with transthyretin (TTR) in plasma to form the holo-RBP/TTR complex — this large complex is not filtered by glomeruli, allowing retinol to circulate without renal loss. Serum RBP4 levels reflect hepatic retinol release, and isolated zinc deficiency impairs RBP4 synthesis, causing functional retinol deficiency even when liver stores are adequate — another reason zinc status matters for vitamin A biology.

Target cell uptake. STRA6 is the primary cell-surface receptor for retinol uptake from circulating holo-RBP; it was molecularly identified by Sun's group in 2007. STRA6 also signals through JAK-STAT5 activation upon retinol binding, linking retinol uptake to downstream transcriptional programs. STRA6 is expressed in retinal pigment epithelium, choroid plexus, Sertoli cells, brain capillary endothelium, kidney, and select other tissues. Alternative uptake mechanisms include RBPR2 (a second retinol receptor) and passive uptake from retinol unbound to RBP4.

Intracellular retinol metabolism. Once internalized, retinol can be stored as retinyl esters via intracellular LRAT and DGAT1 (diacylglycerol acyltransferase 1), oxidized to retinal via retinol dehydrogenases (RDH10 is the major enzyme in early embryogenesis and adult tissues), or consumed in cell-type-specific pathways. In photoreceptors, retinal is isomerized to 11-cis-retinal and loaded onto opsin. In other cells, retinal is further oxidized by retinal dehydrogenases (RALDH1, RALDH2, RALDH3, also known as ALDH1A1/A2/A3) to retinoic acid, the high-affinity nuclear receptor ligand. Retinoic acid is transported to the nucleus by cellular retinoic acid binding proteins (CRABP1 primarily cytoprotective; CRABP2 delivers to RAR). Oxidative inactivation of retinoic acid by CYP26A1/B1/C1 generates 4-hydroxy-retinoic acid and downstream polar metabolites that are cleared.

The visual cycle in detail. 11-cis-retinal is covalently attached via Schiff base to Lys296 of rhodopsin (or the equivalent in cone opsins). Photon absorption (peak sensitivity ~500 nm for rhodopsin) isomerizes the 11-12 cis double bond to trans, producing bathorhodopsin and a cascade through intermediates to metarhodopsin II — the active G-protein-coupling state. Metarhodopsin II activates transducin (Gt), which activates cGMP phosphodiesterase 6 (PDE6), hydrolyzing cGMP and closing cGMP-gated cation channels, hyperpolarizing the photoreceptor. All-trans-retinal dissociates from opsin, is reduced to all-trans-retinol by RDH8 in photoreceptors, transferred via interphotoreceptor retinoid binding protein (IRBP) to retinal pigment epithelium, esterified by LRAT, isomerized back to 11-cis-retinol by RPE65 (the visual cycle isomerase), oxidized to 11-cis-retinal by RDH5, and shuttled back to photoreceptors via IRBP to regenerate functional rhodopsin. RPE65 deficiency causes Leber congenital amaurosis; voretigene neparvovec (Luxturna) restores RPE65 via AAV2 gene therapy.

Nuclear receptor signaling. RAR and RXR are type II nuclear receptors that reside in the nucleus pre-bound to DNA retinoic acid response elements (RAREs) as RAR/RXR heterodimers in corepressor complexes (NCoR, SMRT, HDACs). Retinoic acid binding to RAR triggers corepressor release and coactivator recruitment (SRC-1/2/3, p300/CBP, Mediator, SWI/SNF), activating target gene transcription. Canonical RARE consensus is two direct-repeat half-sites AGGTCA separated by 5 bp (DR5) or 2 bp (DR2). Hundreds of genes carry functional RAREs, including: HOXA/B/C/D cluster genes (embryonic patterning), Cdx1 and Cdx2, Meis genes (limb patterning), Tgfb family, cytokeratin genes, retinol metabolism genes (autoregulation via CYP26A1 RARE), RAR itself, apolipoproteins, and many immune-relevant genes. RXR heterodimerizes with VDR (vitamin D signaling), TR (thyroid hormone signaling), PPAR-α/δ/γ (fatty acid and lipid signaling), LXR (cholesterol sensing), FXR (bile acid sensing), PXR and CAR (xenobiotic sensing) — making RXR a master hub for metabolic and endocrine integration. Dietary retinoid status modulates the tone of all these networks, which is why hypervitaminosis A disrupts vitamin D3-dependent calcium metabolism and bone biology.

Non-genomic retinoid actions include direct effects on cytoplasmic signaling kinases (activation of p38 MAPK and ERK by CRABP2/PKCα), regulation of ion channels in neurons, and modulation of CaMKII and other calcium-dependent signaling. These rapid (seconds to minutes) effects are distinct from the slower (hours) genomic transcriptional response.

Cellular differentiation and development. Retinoic acid is the classic teratogen for a reason — it is also the master regulator of anterior-posterior patterning in early embryogenesis. Both deficiency and excess disrupt neural crest, hindbrain, limb, cardiac, and reproductive tract development. Maternal retinoid homeostasis is therefore tightly regulated; aldh1a2 knockout mice (loss of RALDH2) die embryonically from severe cardiac and axial defects.

Therapeutic retinoid mechanisms. In acute promyelocytic leukemia (APL), PML-RARα fusion protein formed by t(15;17) translocation binds DNA at RAR targets but recruits corepressors constitutively, blocking myeloid differentiation at the promyelocyte stage. Pharmacologic ATRA (tretinoin, 45 mg/m²/day) reaches concentrations that trigger PML-RARα degradation through the proteasome and release the differentiation block — terminally differentiating leukemic cells into neutrophils. Combined with arsenic trioxide (which also degrades PML-RARα by a distinct mechanism), this regimen produces >90% complete remission rates and >85% 5-year survival in APL (Hu 2009; Lo-Coco 2013, PMID 23841729). Isotretinoin's acne mechanism appears multifactorial: shrinkage of sebaceous glands via induction of apoptosis in sebocytes, reduction of sebum triglyceride production, normalization of follicular keratinization, and modulation of Cutibacterium acnes colonization downstream of reduced sebum. Topical tretinoin increases epidermal turnover, reduces microcomedone formation, and over months increases dermal collagen deposition — the basis of both anti-acne and anti-aging effects.

Vitamin A is the fat-soluble vitamin family encompassing three interconvertible oxidation states — retinol (the alcohol form, the primary transport and storage species), retinal (the aldehyde, the vision-critical form), and retinoic acid (the carboxylic acid, the nuclear receptor ligand) — along with the provitamin A carotenoids, chiefly β-carotene, that plants use to provide animals a dietary precursor. The vitamin earned four distinct "vitamin A" designations across its history: the anti-xerophthalmic factor (night blindness), the anti-infective factor, the growth factor, and the epithelial differentiation factor. All four are the same molecule operating through overlapping biochemistry. Elmer McCollum and Marguerite Davis at Wisconsin isolated it in 1913 as "fat-soluble A," distinct from water-soluble B, and the structural characterization by Paul Karrer in Switzerland earned him a share of the 1937 Nobel Prize in Chemistry. George Wald won the 1967 Nobel in Physiology or Medicine for working out the visual cycle role of 11-cis-retinal as the prosthetic group of rhodopsin. The discovery of RAR (1987, Chambon and Dejean groups) and RXR (1990, Mangelsdorf, Evans, Chambon) as nuclear hormone receptors cemented retinoic acid's status as a true hormone, not merely a vitamin.

Structurally, retinol is a 20-carbon diterpenoid built from an isoprenoid polyene chain terminating in a cyclohexenyl ring, with a primary alcohol at the other end. The conjugated double-bond system is why the molecule absorbs visible-adjacent UV and drives vision chemistry. β-Carotene is a C40 symmetrical tetraterpenoid with a central double bond that intestinal β-carotene 15,15'-dioxygenase (BCO1) cleaves to yield two retinal molecules in principle, though the in vivo conversion ratio is far from 2:1 — BCO1 polymorphisms reduce conversion efficiency by up to 70% in a substantial minority of the population (Leung 2009; Lietz 2012), which explains persistent vitamin A insufficiency in populations eating plenty of orange vegetables but no animal foods. Preformed vitamin A (retinyl esters from liver, egg yolk, dairy fat, oily fish, cod liver oil) is absorbed 70-90% efficiently; β-carotene retinol equivalence is roughly 12:1 by mass in mixed diets per the Institute of Medicine's 2001 revision. RDA for adults is 900 μg RAE for men and 700 μg RAE for women; tolerable upper intake level from preformed vitamin A is 3,000 μg/day (10,000 IU) for chronic daily consumption.

After intestinal uptake, retinyl esters are incorporated into chylomicrons and delivered primarily to hepatic stellate cells, which are the body's master vitamin A reservoir; the liver of a healthy adult stores roughly 50-500 mg retinol equivalents, enough to buffer weeks to months of dietary inadequacy. When needed, retinol is mobilized from stellate cells, bound to serum retinol binding protein (RBP4) produced in hepatocytes, complexed with transthyretin (TTR) for transport, and delivered to target tissues via the STRA6 membrane receptor (discovered by the Sun lab in 2007). Inside target cells, retinol can be esterified for storage by LRAT, oxidized to retinal by alcohol dehydrogenases and retinol dehydrogenases (RDH), oxidized further to retinoic acid by retinal dehydrogenases (RALDH1/2/3), or consumed in the visual cycle. Cellular retinoic acid binding proteins (CRABP1/2) then chaperone retinoic acid to either the nuclear receptors or the cytochrome P450 CYP26 family for oxidative inactivation.

Three major mechanisms define vitamin A's biology. First, vision. In rod and cone photoreceptors, 11-cis-retinal is covalently linked via Schiff base to a lysine in opsin (rod opsin, and three cone opsins tuned to different wavelengths). Photon absorption isomerizes the cis bond to trans, triggering a conformational change in opsin that activates the G-protein transducin, which activates cGMP phosphodiesterase, dropping cGMP and closing cGMP-gated sodium channels — the visual signal. All-trans-retinal then dissociates, travels to retinal pigment epithelium, gets re-isomerized to 11-cis through the RPE65-centered visual cycle, and returns to photoreceptors. Loss of RPE65 causes Leber congenital amaurosis type 2, corrected by the AAV2 gene therapy voretigene neparvovec (Luxturna, first FDA-approved gene therapy for a genetic eye disease, 2017). Night blindness — the earliest sign of vitamin A deficiency — reflects rod dysfunction because rhodopsin has the highest turnover and depletes first.

Second, nuclear receptor signaling. All-trans-retinoic acid (ATRA) is the high-affinity ligand for RAR α/β/γ; 9-cis-retinoic acid (debated whether it is endogenously produced in meaningful quantities) is a ligand for RXR α/β/γ. RAR/RXR heterodimers bind DNA at retinoic acid response elements (RAREs, canonical DR5 and DR2 direct repeats) and regulate several hundred genes: HOX genes governing anterior-posterior patterning in embryonic development, Meis genes for limb patterning, genes involved in keratin gene expression, genes driving erythropoiesis and myeloid differentiation, TGF-β pathway components, and dozens of metabolic genes. RXR is a universal heterodimer partner — it pairs with RAR for retinoid signaling, but also with the vitamin D receptor (VDR) for vitamin D signaling, with thyroid receptor (TR) for thyroid signaling, and with PPAR α/δ/γ for lipid signaling. This means retinoid status modulates the tone of vitamin D, thyroid, and lipid-sensing networks — a deep cross-talk explaining why retinoid excess can disrupt calcium metabolism and bone biology.

Third, immune and epithelial function. Retinoic acid induces peripheral regulatory T cells (Tregs) and promotes IgA class-switching in gut-associated lymphoid tissue — a major mechanism of mucosal immunity. In WHO-supervised trials, vitamin A supplementation of children 6-59 months in low-resource settings reduced all-cause mortality by approximately 24% (Mayo-Wilson Cochrane 2011), with particular benefit for diarrheal and measles-associated mortality. Vitamin A also governs epithelial differentiation and keratinization; severe deficiency produces follicular hyperkeratosis (rough, bumpy skin), squamous metaplasia of respiratory and urogenital epithelia, and corneal xerophthalmia progressing through Bitot's spots to keratomalacia and corneal perforation — the most common preventable cause of childhood blindness globally.

Four therapeutic retinoids deserve specific mention as they connect the vitamin to modern medicine. Tretinoin (ATRA) is FDA-approved topically for acne and photoaging and systemically for acute promyelocytic leukemia (APL). The APL story is one of the great triumphs of modern oncology: patients with the t(15;17) PML-RARα translocation have a block at the promyelocyte stage; pharmacologic ATRA dissociates the PML-RARα repressor complex and drives terminal differentiation into mature granulocytes — converting a rapidly fatal leukemia into a cancer with >90% long-term survival when ATRA is combined with arsenic trioxide (Hu 2009). Isotretinoin (13-cis-retinoic acid) is the dermatology nuclear option for severe nodular acne; it profoundly shrinks sebaceous glands, reduces sebum production by >80%, and often produces durable remission after a single 16-24 week course. Isotretinoin is a category X teratogen causing characteristic embryopathy (craniofacial, cardiac, CNS, thymic anomalies), necessitating the iPLEDGE program of mandatory contraception and pregnancy testing in the United States. Alitretinoin (9-cis-retinoic acid) is approved in Europe for severe chronic hand eczema. Bexarotene (Targretin) is an RXR-selective retinoid approved for cutaneous T-cell lymphoma.

The β-carotene smoking cancer signal is a crucial cautionary tale. Two large randomized trials — ATBC in Finnish male smokers (Alpha-Tocopherol, Beta Carotene Cancer Prevention, PMID 8127329, 1994) and CARET in US smokers and asbestos-exposed workers (Beta-Carotene and Retinol Efficacy Trial, PMID 8602180, 1996) — unexpectedly found higher lung cancer incidence and mortality in the β-carotene supplementation arms, roughly 18-28% increased lung cancer risk at 20-30 mg/day β-carotene vs. placebo. The mechanism is still debated (oxidative stress in smoke-exposed lung tissue, pro-oxidant behavior of β-carotene at high tissue concentrations, interaction with tobacco carcinogen activation) but the clinical lesson is clear: high-dose β-carotene supplementation in current or recent smokers is harmful. β-carotene from food is not implicated. Preformed vitamin A at nutritional doses remains safe.

Hypervitaminosis A is the main toxicity concern. Acute hypervitaminosis A (liver ingestion of polar bear, seal, or certain fish livers, or industrial accidents) causes headache, nausea, vomiting, vertigo, and skin desquamation. Chronic hypervitaminosis A from long-term supplementation above 10,000 IU/day causes headache, dry skin, alopecia, hepatotoxicity, hepatic fibrosis, pseudotumor cerebri, bone loss and increased fracture risk (Melhus 1998; Michaelsson 2003), and in pregnancy, teratogenicity. The margin between "adequate" and "toxic" is narrower for preformed vitamin A than for most other vitamins — another reason to prefer B-carotene-containing foods and moderate preformed intake.

BodyHackGuide's take: vitamin A is essential, non-trivially toxic in excess, and almost uniquely among vitamins implicated in nuanced drug-like therapy (APL, severe acne, CTCL). For the healthy adult eating a varied diet with occasional liver, egg yolks, dairy, oily fish, and orange/green vegetables, dietary intake is sufficient and supplementation unnecessary. For populations at risk (low-resource children, severe malabsorption, cystic fibrosis, cholestatic liver disease), targeted supplementation under clinical guidance follows established protocols. High-dose β-carotene supplementation in smokers is contraindicated. Topical and systemic prescription retinoids operate at different doses and through related but distinct receptor biology — consult dermatology or oncology, not a general supplement aisle. The vitamin belongs in the fat-soluble family alongside vitamin D3, vitamin E, and vitamin K2, with particular attention to zinc-dependent retinol binding protein biology.

IUPAC Name

Not yet available

CAS Number

Not yet available

Molecular Formula

Not yet available

Molecular Mass

Not yet available

Unlock Dosing Protocols

Free account gets you:

• View beginner, intermediate & advanced protocols
• See weight-based dosing calculations
• Access cycle length & frequency data

2,800+ researchers already in

Unlock Research Data

Free account gets you:

• Browse PubMed study summaries
• See clinical trial phases & results
• Access mechanism of action details

2,800+ researchers already in

Get Vitamin A Price Drop Alerts

Set a target price and we'll notify you when any vendor drops below it.

Related Compounds

Data Completeness

Research Credibility